Results 111 to 120 of about 7,222 (160)

Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses. [PDF]

Sci Adv
Ng WW, Sugrue J, Rosa Duque JS, Rouilly V, Bondet V, Albert C, Dubois F, Robert M, Leung D, Chung P, Luk THY, Li ABS, Hung RL, Villain E, Briard M, Yip G, Consortium MI, Larocque D, Patin E, Quintana-Murci L, Leung GM, Ni MY, Goncalves P, Schwartz O, Di Santo J, Bruzzone R, Peiris M, Lau YL, Duffy D.   +28 more
europepmc   +1 more source

Association Between Periodontal Health Status and COVID-19 Severity: A Cross-Sectional Study. [PDF]

Medicina (Kaunas)
Kanmaz MG, Kanmaz B, Ayvat P, Sorsa T, Meriç Kantar P, Buduneli N.   +5 more
europepmc   +1 more source

Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial. [PDF]

Nat Commun
Hart JD, Fadlyana E, Mazarakis N, Putri ND, Watts E, Moore KA, Neal EFG, Setiabudi D, Putra MGD, Nguyen C, Zhafira AS, Wicaksana P, Sinto R, Oktavia D, Fajarani R, Indrati AR, Murad C, Hartantri Y, Suryadinata H, Sofiatin Y, Rusmil K, Satari HI, Hadinegoro SR, Kartasasmita CB, Sundoro J, Licciardi PV, von Mollendorf C, Mulholland EK.   +27 more
europepmc   +1 more source

Single-cell transcriptomics reveals pediatric immune responses to COVID-19 vaccination. [PDF]

iScience
Zhu X, Wang J, Wang X, Feng Z, Wan L, Sun L, Fu J, Xiao F, Huang X, Jia N, Chen M, Zhou J, Wang Y, Wang Q.   +13 more
europepmc   +1 more source

Dermatofibrosarcoma Protuberans at the Presumed Injection Site following CoronaVac COVID-19 Vaccination: A Case Report. [PDF]

Case Rep Dermatol
Cao X, Yin R, Lv D, Xu Z, Hu Z, Tang B.
europepmc   +1 more source

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses. [PDF]

mSphere
Wangteeraprasert A, Pongcharoen S, Ngoenkam J, Makanut S.   +3 more
europepmc   +1 more source

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity. [PDF]

BMC Med
Méndez C, Rodríguez-Guilarte L, Palacios PA, Gutierrez-Vera C, Román F, Moreno-Tapia D, Ríos M, Reyes A, Cancino FA, Otero FF, Zurita C, Rivera D, Cabrera A, Duarte LF, Urzúa M, Iturriaga C, Rojas Á, Perez CM, Redlich AS, Fasce RA, Fernández J, Mora J, Ramírez E, Domínguez A, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W, Goldbatt D, Johnson M, CoronaVarCL study group, González-Aramundiz JV, Álvarez-Figueroa MJ, Abarca K, Carreño LJ, González PA, Kalergis AM, Peñaloza HF, Bueno SM.   +39 more
europepmc   +1 more source

Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses. [PDF]

Front Immunol
Caetano BLL, Pinto PBA, Pacheco AR, Lage AR, Pereira ASG, Nascimento AVP, Machado TR, Paulino A, Medeiros TL, Fernandes-Siqueira LO, Da Poian AT, Horbach IS, Azevedo AS, Costa SM, Alves AMB.   +14 more
europepmc   +1 more source

Estimating the Waning Effectiveness of COVID-19 Vaccines From Population-Level Surveillance Data in Hong Kong. [PDF]

J Infect Dis
Chen H, Huang X, Wang C, Cowling BJ, Tsang TK.   +4 more
europepmc   +1 more source

Prevalence of herpes zoster in individuals who have received COVID-19 vaccine and/or had COVID-19: a cross-sectional study. [PDF]

BMC Infect Dis
Ispir NG, Pamukcu U, Ispir AH, Peker I, Toraman M.   +4 more
europepmc   +1 more source